XML 29 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Class A and Class B Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Total
Beginning balance at Dec. 31, 2017   $ 377,809 $ (18,540) $ (379) $ (309,576) $ 2,474 $ (379) $ 52,167
Balance at the beginning (in shares) at Dec. 31, 2017           247,465,176    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income         142,112     142,112
Other comprehensive income (loss)     (10,874)         (10,874)
Dividends declared         (20,005)     (20,005)
Profit sharing plan shares, net         (3,382) $ (5)   (3,387)
Profit sharing plan shares, net (in shares)           (465,979)    
Shares issued in connection with deferred compensation plan         (6,884) $ 23   (6,861)
Deferred compensation arrangement with individual, shares issued (in shares)           2,332,585    
Deferred compensation plan voluntary contributions and vesting of awards   4,504           4,504
Payment of shareholder Put and Call rights         (8,560) $ (11)   (8,571)
Payment of shareholder Put and Call rights (in shares)           (1,131,928)    
Value of shares issued for cash   13     (9,673) $ (13)   (9,673)
Common Stock Purchase Agreement, net (in shares)           (1,281,633)    
Stock option exercises, net   2,151     (1,569) $ 28   610
Stock option exercises, net (in shares)           2,812,998    
Stock-based compensation expense   7,882           7,882
Shares related to restricted stock, net   494     (637) $ 6   (137)
Shares related to restricted stock, net (in shares)           546,783    
Other   43           43
Other (in shares)           5,511    
Ending balance at Dec. 31, 2018 $ 2,502 392,896 (29,414) 107,822 (218,553) $ 2,502 107,822 147,431
Balance at the end (in shares) at Dec. 31, 2018           250,283,513    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income         66,845     66,845
Other comprehensive income (loss)     5,778         5,778
Dividends declared         (19,023)     (19,023)
Shares issued in connection with deferred compensation plan $ 22       (4,994)     (4,972)
Deferred compensation arrangement with individual, shares issued (in shares) 2,233,807              
Deferred compensation plan voluntary contributions and vesting of awards   2,664           2,664
Payment of shareholder Put and Call rights $ (6)       (4,946)     (4,952)
Payment of shareholder Put and Call rights (in shares) (632,859)              
Stock option exercises, net $ 30 3,009     (2,255)     784
Stock option exercises, net (in shares) 2,979,031              
Stock-based compensation expense   6,046           6,046
Shares related to restricted stock, net $ 4 (4)     (344)     (344)
Shares related to restricted stock, net (in shares) 402,250              
Other   40     (17)     23
Other (in shares) 5,290              
Ending balance at Sep. 30, 2019 $ 2,550 405,117 (23,636)   (77,448)     306,583
Beginning balance at Dec. 31, 2018 2,502 392,896 (29,414) 107,822 (218,553) $ 2,502 107,822 147,431
Balance at the beginning (in shares) at Dec. 31, 2018           250,283,513    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income         103,096     103,096
Other comprehensive income (loss)     5,487         5,487
Dividends declared         (25,390)     (25,390)
Profit sharing plan shares, net         (2,414) $ (3)   (2,417)
Profit sharing plan shares, net (in shares)           (318,203)    
Shares issued in connection with deferred compensation plan         (5,632) $ 23   (5,609)
Deferred compensation arrangement with individual, shares issued (in shares)           2,322,983    
Deferred compensation plan voluntary contributions and vesting of awards   3,586           3,586
Payment of shareholder Put and Call rights         (8,827) $ (11)   (8,838)
Payment of shareholder Put and Call rights (in shares)           (1,126,747)    
Value of shares issued for cash   466     (48)     418
Common Stock Purchase Agreement, net (in shares)           (64,509)    
Stock option exercises, net   3,579     (2,309) $ 33   1,303
Stock option exercises, net (in shares)           3,214,542    
Stock-based compensation expense   8,091           8,091
Shares related to restricted stock, net   (4)     (399) $ 4   (399)
Shares related to restricted stock, net (in shares)           395,336    
Other   53     (15)     38
Other (in shares)           7,016    
Ending balance at Dec. 31, 2019 2,548 408,667 (23,927) $ 107,822 (52,669) $ 2,548 $ 107,822 334,619
Balance at the end (in shares) at Dec. 31, 2019           254,842,949    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income         74,589     74,589
Other comprehensive income (loss)     (5,284)         (5,284)
Dividends declared         (415,748)     (415,748)
Shares issued in connection with deferred compensation plan $ 30       (1,907)     (1,877)
Deferred compensation arrangement with individual, shares issued (in shares) 2,984,531              
Deferred compensation plan voluntary contributions and vesting of awards   2,602           2,602
Payment of shareholder Put and Call rights $ (1)       (1,453)     (1,454)
Payment of shareholder Put and Call rights (in shares) (128,176)              
Stock option exercises, net $ 35 7,741     (3,618)     4,158
Stock option exercises, net (in shares) 3,506,103              
Stock-based compensation expense   22,510           22,510
Shares related to restricted stock, net $ 15 (16)     (133)     (134)
Shares related to restricted stock, net (in shares) 1,553,883              
Ending balance at Sep. 30, 2020 $ 2,622 $ 441,723 $ (29,211)   $ (407,961)     $ 7,173